Express Scripts, CVS Face ERISA Suit Over EpiPen Costs

By Dani Kass · June 5, 2017, 6:16 PM EDT

Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In re EpiPen ERISA Litigation (Klein et al v. Prime Therapeutics, LLC et al)

Case Number

0:17-cv-01884

Court

Minnesota

Nature of Suit

Labor: E.R.I.S.A.

Date Filed

June 02, 2017